• Home
  • Team
  • Research
  • Publications & Media
  • Microbiome Research Center
  • Lectures & Seminars
  • Contact
  • Home
  • Team
  • Research
    • C3Z Lighthouse project
    • Inflammation
      • The impact of Nano- and Microparticles
      • Crohn's disease and fistula
      • The role of GP96 in the intestinal epithelium
      • PTPN2 in chronic inflammatory liver disease
      • PTPN2 for the treatment of IBD
      • The role of epithelial cells differentatiation in the pathogenesis of celiac disease
    • Microbiome
      • Selected Clostridiales bacterias as novel treatment for solid tumors
      • Unravelling the mechanism behind the anti-tumor effect of commensal gut microbes in solid tumors
      • Impact of the intestinal microbiome on colorectal cancer metastasis
    • Cancer
      • SKAP2 in IBD and colorectal cancer
      • PTPN23 in colorectal cancer
      • PTPN2 and colorectal cancer
      • Integrin αvβ6 in colorectal cancer
      • Checkpoint inhibitor therapy
  • Publications & Media
  • Microbiome Research Center
    • FMT in malignancies not responding to ICI
    • Modulation of the gut microbiome for cancer therapy
  • Lectures & Seminars
  • Contact

    Sitemap

    • Home
    • Team
    • Research
      • C3Z Lighthouse project
      • Inflammation
        • The impact of Nano- and Microparticles
        • Crohn's disease and fistula
        • The role of GP96 in the intestinal epithelium
        • PTPN2 in chronic inflammatory liver disease
        • PTPN2 for the treatment of IBD
        • The role of epithelial cells differentatiation in the pathogenesis of celiac disease
      • Microbiome
        • Selected Clostridiales bacterias as novel treatment for solid tumors
        • Unravelling the mechanism behind the anti-tumor effect of commensal gut microbes in solid tumors
        • Impact of the intestinal microbiome on colorectal cancer metastasis
      • Cancer
        • SKAP2 in IBD and colorectal cancer
        • PTPN23 in colorectal cancer
        • PTPN2 and colorectal cancer
        • Integrin αvβ6 in colorectal cancer
        • Checkpoint inhibitor therapy
    • Publications & Media
    • Microbiome Research Center
      • FMT in malignancies not responding to ICI
      • Modulation of the gut microbiome for cancer therapy
    • Lectures & Seminars
    • Contact

    Scharl Lab

    Department of Gastroenterology and Hepatology

    University Hospital Zurich, University of Zurich

    Rämstrasse 100

    8091 Zurich

    Switzerland

    CONTACT
    USZ Universitätsspital Zürich
    University of Zurich

    Impressum | Datenschutz | Cookie-Richtlinie | Sitemap
    Abmelden | Bearbeiten
    • Nach oben scrollen